Introduction
Angelica dahurica ((Fisch. ex Hoffm.) Benth. et Hook. f (Baizhi in Chinese)) is one of the widely used traditional Chinese medicines as a common acesodyne. It has strong effects on headache, toothache, antipyretic, analgesic for cold and antimicrobial. [1] [2] [3] The major effective components of this herb are coumarins and furanocoumarins including imperatorin, isoimperatorin, psoralen and oxypeucedanine. 4, 5 Pharmacological studies and clinical practice demonstrated that they have remarkable anticancer, antibacterial, and codein effects. 6 They are often used as reference standards in the quality control of Baizhi and its products. A number of studies have been performed on the isolation and identification of the constituents of these furanocoumarins. Analytical studies mostly deal with gas chromatography (GC) and GC coupled with mass spectrometry (MS) methods. 7 Pharmacological trials have indicated that imperatorin, 9-(3-methylbut-2-enyloxy)-7H-furo[3,2-g]chromen-7-one ( Fig. 1C) , is one of the major active constituents in the essential oil from Angelica dahurica. 8 In addition to its anticarcinogenic properties, imperatorin has been shown to possess anti-hypertention activities. It could inhibit a voltage-dependent calcium channel and receptormediated Ca 2+ influx and release, and partly open a calciumactivated potassium channel and the competitive antagonism of 5-HT receptors. 9 In this study, we developed a gas-chromatography selected ion monitoring (SIM) mass spectrometry method for the determination of imperatorin from Angelica dahurica in rats. A rapid and sensitive assay for the quantification of imperatorin in plasma and tissues has been developed. An analysis was performed by gas chromatography/mass spectrometry in the selected ion-monitoring mode. The main pharmacokinetic parameters obtained were Tmax = 1.23 ± 0.26 h, Cmax = 0.95 ± 0.38 µg/mL, AUC = 3.42 ± 0.52 h µg/mL and Ka = 1.34 ± 0.18 h. The experimental results showed that imperatorin was easily absorbed, but its elimination was slow, from 3 to 12 h after oral administration. The concentrations of imperatorin in rat liver, kidney, lung, and heart were higher than those in other organs. To determine the free fraction in serum, samples were filtered using ultrafiltration membranes with a molecular weight cut-off of 10 kDa, and extracted using liquid-liquid extraction. The protein binding values in rat plasma, spontaneous hypertensive rat plasma, human plasma and human serum albumin were 84 ± 3, 69 ± 7, 81 ± 7 and 75 ± 3%, respectively. Technologies, USA) was used. The inlet temperature was maintained at 280 C. The column oven was held at 140 C for 2 min, then programmed from 140 to 280 C at 10 C/min and, finally, held for 4 min. Helium at a constant flow rate of 2.0 mL/min was used as the carrier gas. Data were collected using GC/MS analysis Station software. The mass spectrometry conditions were as follows: SIM mode; ionization energy, 70 eV; ion source temperature, 200 C. The mass selective detector was operated in the SIM mode (imperatorin, 202; osthole, 244). The data were analyzed by a NIST library (Shimadzu, Kyoto, Japan).
Development and Validation of a gas

Animals
SD rats, weighing 225 -275 g, were maintained under standard conditions with normal access to food and water. The rats were initially anesthetized with ether, and remained anesthetized throughout the femoral artery cannulated surgery period. The femoral artery was exposed for further drug administration. The rats were recovering from anesthesia before the test.
Preparation of imperatorin
Angelica dahurica was ground to 40 mesh, and extracted by 95% alcohol. The extracts were extracted by using petroleum ether, ethyl ether, AcOEt and butanol by turns. Then, five parts were obtained.
The petroleum ether part was systematically separated by using column chromatographic methods. Firstly, a 7-g sample was subjected to a normal phase column chromatography (CC, Silica Gel, 3 × 200 g) using a mixture solution of petroleum ether/ethyl ether from (5:1) to (1:1) as a mobile phase, to give 8 fractions (5 × 100 mL each fraction) after recombination. Fraction 1 (2.7 g) was subjected to a further separation, then two needle crystal substances were obtained (purity: >98% by HPLC). One was identified as imperatorin by means of the GC/MS method, for the following analysis. 10, 11 The prepared imperatorin was used for treating rats.
Standard stock solutions
A standard stock solution was prepared by dissolving 12.7 mg of imperatoin and 11.7 mg osthole in 10 mL of AcOEt/petroleum ether (1:1) to yield a nominal concentration of 1.27 and 1.17 mg/mL. And, the solutions were kept at -20 C before use. Stock solutions were diluted with AcOEt/petroleum ether (1:1) to obtain calibration solutions (range 0.025 -10.16 µg/mL). Internal standard solutions were prepared by dilution of the stock solution to a concentration of 4.68 µg/mL, osthole.
Preparation of assay standard samples
Imperatorin standard plasma samples (0.025, 0.127, 0.508, 1.27, 5.08 and 10.16 µg/mL) were prepared by spiking 200 µL of blank blood with 20 µL of a standard stock solution and 10 µL of the internal standard solution (4.68 µg/mL) prepared as mentioned above. Imperatorin standard tissue samples (0.025, 0.127, 0.508, 1.27, 5.08 and 10.16 µg/mL) were prepared by spiking 500 µL of blank tissue homogenate with 50 µL of the standard stock solution and 20 µL of the internal standard solution (4.68 µg/mL) prepared as described above.
Samples were processed as described below, and the peak-area ratios of imperatorin/osthole were calculated. Quality control samples to determine the accuracy and precision of the method were independently prepared by standard plasma solution at low (0.025 µg/mL), medium (0.508 µg/mL) and high (5.08 µg/mL) concentrations. Extraction yields were determined by comparing the peak-area ratios after extraction from the plasma with the peak-area ratios of not extracted standards. All samples were stored at -20 C until analysis.
Extraction procedure for bio-samples
All experimental protocols involving animals were reviewed and approved by the Institutional Animal Experimentation committee of Xi'an Jiaotong University. Each rat (n = 10) was administrated an oral dose of 10 mg/kg of imperatorin and divided into two groups. The first group was used to collect blood samples (0.5 mL each) at 0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0 and 12 h after administration. All blood samples were transferred to heparinized tubes. After centrifugation (10 min at 1500g), the supernatant liquid was quantitatively transferred into clean tubes and stored at -20 C until further analysis.
Tissue samples were immediately collected from the second group of rats at 1.73 h after administration, including heart, liver, spleen, lung, kidney, cerebrum and cerebellum, and put into the physiological saline to exclude the remaining bloodstain. They were weighed, and about 0.5 g was taken for each as analytical samples after drying any moisture with filter paper. Tissue homogenate (4.0 mL for each) was obtained as the tissue samples, transferred to a heparinized tube and stored at -20 C until it was time for the treatment.
A liquid-liquid extraction method was used for the extraction of imperatorin in bio-samples. To each plasma and tissue samples, 10 µL of the internal standard (4.68 µg/mL) was added to 200 µL of plasma samples, or 20 µL of the internal standard (4.68 µg/mL) was added to 500 µL of tissue samples in glass centrifuge tubes. Next, 1.0 mL (for plasma samples) and 2.5 mL (for tissue samples) of AcOEt/petroleum ether (1:1) were added, and the mixture was vortexed for 5 min. After centrifugation for 10 min at 4000 rpm, the upper organic layer was transferred to a clean tube. The organic solution was evaporated under a stream of nitrogen at 40 C. To the residue, 0.1 mL of AcOEt/petroleum ether (1:1) was added, and the centrifugation procedure was repeated. An aliquot (2 µL) of the supernatant was injected into the GC/MS systems for analysis.
Protein binding ratio
Plasma protein binding of imperatorin was determined by an ultrafiltration technique using a micropartition system (Centrifree, Millipore, Bedford, MA). Rats or human plasma or solutions of HSA aliquots (1.0 mL) containing various concentrations of imperatorin (1.7, 1.02, 0.21 µg/mL) were incubated for 4 h at 37 C. Then, the aliquots (500 µL) were transferred to ultrafiltration tubes with a filter pore size of 10 kDa and centrifuged at 3000g for 30 min at 25 C. The filtrate (50 µL) was analyzed for the drug by GC/MS. The measurement of imperatorin was the same as the plasma samples. The fraction of drug unbound was determined by the following equation: fu = Cu/Ct. Here, fu is the fraction of drug unbound in the plasma; Cu and Ct are the unbound and total concentrations of the drug in plasma, respectively.
Statistical analysis
The pharmacokinetic parameters of imperatorin in rats were calculated by the 3p97 software supplied by the Pharmacological Society of China (Beijing, China). The tissue distributions of imperatorin in rats tissue were evaluated by measuring the concentrations of imperatorin at 1.73 h after oral administration (for about 30 min after the time of Tmax). All data were expressed as means ± standard deviation. The statistical differences were estimated with the student's test.
Results and Discussion
Chromatography
Typical GC-SCAN chromatograms, mass-spectrogram and structure formula obtained for imperatorin standard and osthole standard are shown in Fig. 1 , as analyzed by GC-MS in the electron impact (EI) mode. The retention time of imperatorin was 12 min, and osthole was 11 min. It is obvious that the GC-SCAN chromatograms and mass-spectrogram can provide an elective ion and time program: from 3 -12 min m/z was 244 (osthole) and from 12 -20 min m/z was 202 (imperatorin).
The GC-SIM chromatograms obtained for blank samples, imperatorin standard and osthole standard, blank tissue samples and tissue samples are shown in Fig. 2 , as analyzed by GC-MS. The presence of specific fragmentations, such as m/z of 244 and 202, are shown in Fig. 2 . It is obvious that the GC-SIM method simplifies the chromatogram very efficiently, and provides a single peak for identification.
Linear calibration curves were obtained in the given concentration range of imperatorin in plasma samples and each tissue sample, respectively. Standard curves were fitted to a first-degree polynomial, y = ax + b, where y is the peak area of imperatorin/osthole; a and b were constants, and x is the imperatorin concentration (µg/mL). Typical values for the regression parameters and the concentration range of the different sample are listed in Table 1 . The limit of quantification (LOQ) was expressed as the lowest concentration in the linear calibration curve. The limits of detection (LOD) of the method were measured to be up to 1 ng/mL of imperatorin (S/N ≥ 3).
Obviously, the method provides accuracy and selectivity for the determination of imperatorin. However, for an accurate quantitation, it is necessary to estimate the recovery under different situations. Table 2 gives a summary of the recoveries for rat biological samples spiked with different concentrations of imperatorin (0.025, 0.508 and 5.08 µg/mL, n = 5) from 5 normal rats (blank experiments). The recoveries for all samples were > 80%, except for liver samples which were > 70%. The between-day precision ranged from 3.91 to 5.22%, and the within-day precision ranged from 4.72 to 6.52%. The stability of the same concentrations after extraction was evaluated over a period of 24 h, and was expressed as percentage of the nominal concentration. The stability study was only conducted for rat plasma. The results show that the analyte was stable under the conditions investigated in this study, since the measured plasma sample concentrations were all within 83 -91% of the nominal concentrations. The RSDs for the peak areas of imperatorin were 3.16%. These results demonstrate that imperatorin samples were stable for up to 24 h.
Pharmacokinetics analysis
The concentration of imperatorin in a plasma sample was determined by the same method. The plasma imperatorin concentration-time curves were analyzed using the 3p97 program to determine the compartment model, and the pharmacokinetics parameters were calculated. The plasma imperatorin concentration-time curve conformed to the twocompartment with the first absorption model. Figure 3 shows representative plasma concentration-time profiles for an oral administration of 10 mg/kg imperatorin. The pharmacokinetics parameters are summarized in Table 3 . The peak concentration of imperatorin of 0.95 ± 0.38 µg/mL was achieved within about 1 h after administration. The plasma levels then declined rapidly. The area under the plasma concentration-time curve (AUC) was 3.42 ± 0.52 h µg/mL.
Tissue distribution analysis
There was a wide tissue distribution of imperatorin in rats 1.73 h after oral administration, shown in Fig. 4 . The observed distribution consequence in the imperatorin concentration was as follows: liver > heart > kidney > lung > cerebellum > cerebrum > spleen. a. Unit, µg mL -1 . Fig. 3 Mean plasma concentration-time curve of imperatorin in rats after oral administration of imperatorin (10 mg/kg, n = 5). Protein binding ratio Plasma protein binding of imperatorin was determined by the ultrafiltration method. The bound fractions of imperatorin were calculated, and are given in Table 4 . The results indicated that there was about 84 ± 3, 69 ± 7, 81 ± 7, and 75 ± 3% imperatorin binding to the SD rats, SHR, human plasma protein and HSA protein, respectively. And, the binding to the plasma is linear over the concentration range of 0.025 -8.0 µg/mL. The protein binding results showed a statistical significance between SD rat and SHR (P < 0.05). The rates of imperatorin with rat and human plasma were higher than with HSA, which shows that imperatorin could bind to α1-acid glycoprotein, and lipoprotein, except for albumin.
Conclusions
The GC-SIM-MS method for the qualitative and quantitative analysis of imperatorin in rat plasma and tissue is described.
This method has been demonstrated to be usable in pharmacokinetic and tissue distribution studies of imperatorin in Angelica dahurica and it prescriptions. The pharmacokinetic and tissue distribution results achieved may be useful for further studies imperatorin.
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